Rachel Kelly
Papers
1
Total Citations
29
H-Index
1
About
Dr. Rachel Kelly is a leading colorectal surgeon whose research centers on improving surgical outcomes in rectal cancer, with a particular focus on preventing anastomotic leaks—a devastating complication following rectal surgery. Her most impactful work is the landmark IntAct trial, an unblinded randomized controlled trial investigating intraoperative fluorescence angiography with indocyanine green (ICG) to reduce anastomotic leak rates. This study, published in 2025 and already garnering 29 citations, addresses a critical clinical question where prior data had been mixed. By providing robust evidence on the safety and efficacy of ICG angiography, Dr. Kelly’s research directly informs intraoperative decision-making, potentially sparing patients from reoperation, prolonged hospital stays, and life-altering complications. Her contributions bridge the gap between surgical innovation and patient safety, making her a key voice in evidence-based colorectal surgery. With her work shaping guidelines and practice, Dr. Kelly continues to advance the standard of care for rectal cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1